Francesco Craighero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francesco Craighero has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Angela Sanzo-Machuca
Inflammatory Bowel Disease Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
3 shared publications- Azucena Salas
Inflammatory Bowel Disease Unit, Hospital Clínic of Barcelona, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
3 shared publications - Cédric Gobet
Institute of Bioengineering, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL)
3 shared publications Ernest Choy
Section of Rheumatology, Cardiff University, Cardiff, UK
3 shared publicationsFlaminia Pedretti
Experimental Therapeutics Group, Vall d’Hebron Institute of Oncology, Barcelona, Spain
3 shared publicationsFrederique Alleblas
Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, Netherlands
3 shared publications
Latest Publications
- Open Access
- 26 January 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (2) , 765
Publisher Correction: Interpretable inflammation landscape of circulating immune cells
- 26 January 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (2) , 765
Open AccessPublisher Correction: Interpretable inflammation landscape of circulating immune cells
- Top Cited PapersOpen Access
- 12 January 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (2) , 633-644
Interpretable inflammation landscape of circulating immune cells
Inflammation is a biological phenomenon beneficial for homeostasis, but it is unfavorable if dysregulated. Although major progress has been made in characterizing inflammation in specific diseases, a global, holistic understanding is still elusive. This is particularly intriguing, considering its function for human health and the potential for modern medicine if fully deciphered. In this study, we leveraged advances in single-cell transcriptomics to delineate inflammatory processes of circulating immune cells during infection, immune-mediated inflammatory diseases and cancer. Our single-cell atlas of more than 6.5 million peripheral blood mononuclear cells from 1,047 patients (56% female, 43% male) and 19 diseases allowed us to learn a comprehensive model of inflammation in circulating immune cells. The atlas expands current knowledge of the biology of inflammation of immune-mediated diseases, acute and chronic inflammatory diseases, infections and solid tumors and lays the foundation to develop a disease classification framework using unsupervised as well as explainable machine learning. Beyond a disease-centered analysis, we charted altered activity of inflammatory molecules in peripheral blood cells, depicting discriminative inflammation-related genes to further understand mechanisms of inflammation. We present a rich resource for the community and lay the groundwork for learning a classifier for inflammatory diseases, presenting cells in circulation as living biomarkers.
- 12 January 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (2) , 633-644
Top Cited PapersOpen AccessInterpretable inflammation landscape of circulating immune cells
Inflammation is a biological phenomenon beneficial for homeostasis, but it is unfavorable if dysregulated. Although major progress has been made in characterizing inflammation in specific diseases, a global, holistic understanding is still elusive. This is particularly intriguing, considering its function for human health and the potential for modern medicine if fully deciphered. In this study, we leveraged advances in single-cell transcriptomics to delineate inflammatory processes of circulating immune cells during infection, immune-mediated inflammatory diseases and cancer. Our single-cell atlas of more than 6.5 million peripheral blood mononuclear cells from 1,047 patients (56% female, 43% male) and 19 diseases allowed us to learn a comprehensive model of inflammation in circulating immune cells. The atlas expands current knowledge of the biology of inflammation of immune-mediated diseases, acute and chronic inflammatory diseases, infections and solid tumors and lays the foundation to develop a disease classification framework using unsupervised as well as explainable machine learning. Beyond a disease-centered analysis, we charted altered activity of inflammatory molecules in peripheral blood cells, depicting discriminative inflammation-related genes to further understand mechanisms of inflammation. We present a rich resource for the community and lay the groundwork for learning a classifier for inflammatory diseases, presenting cells in circulation as living biomarkers.
- Open Access
- 26 November 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1691
Conditional deep learning model reveals translation elongation determinants during amino acid deprivation
Translation elongation plays a key role in cellular homeostasis, and dysregulation of this process has been implicated in various diseases and metabolic disorders. Uncovering the causes of intragenic heterogeneity of translation, especially in contexts of different amino acid deprivations, could help increase our understanding of these disorders and pave the way for novel therapeutics. Ribosome profiling provides accurate measurements for the genome-wide ribosome footprints, which could be utilized to investigate these mechanisms. Here we present Riboclette, a conditional deep learning model featuring a dual output head that uses the mRNA sequence input to accurately predict the ribosome footprint profiles across six amino acid deprivation conditions. Exploiting standard interpretability methods, we identify specific codons related to deprived amino acids, poly-basic regions, and negatively charged amino acids as the primary drivers of the stalling response. Moreover, we use Riboclette to extract motif level drivers for ribosome stalling by performing in silico perturbation experiments. These motifs precisely explain stalling at different codon positions, allowing for the differentiation between expected determinants of rare stalling events. Our framework offers an accurate and explainable method for understanding the impact of intragenic variations on the regulation of translation elongation under amino acid deprivation.
- 26 November 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1691
Open AccessConditional deep learning model reveals translation elongation determinants during amino acid deprivation
Translation elongation plays a key role in cellular homeostasis, and dysregulation of this process has been implicated in various diseases and metabolic disorders. Uncovering the causes of intragenic heterogeneity of translation, especially in contexts of different amino acid deprivations, could help increase our understanding of these disorders and pave the way for novel therapeutics. Ribosome profiling provides accurate measurements for the genome-wide ribosome footprints, which could be utilized to investigate these mechanisms. Here we present Riboclette, a conditional deep learning model featuring a dual output head that uses the mRNA sequence input to accurately predict the ribosome footprint profiles across six amino acid deprivation conditions. Exploiting standard interpretability methods, we identify specific codons related to deprived amino acids, poly-basic regions, and negatively charged amino acids as the primary drivers of the stalling response. Moreover, we use Riboclette to extract motif level drivers for ribosome stalling by performing in silico perturbation experiments. These motifs precisely explain stalling at different codon positions, allowing for the differentiation between expected determinants of rare stalling events. Our framework offers an accurate and explainable method for understanding the impact of intragenic variations on the regulation of translation elongation under amino acid deprivation.
- Open Access
Conditional Deep Learning Model Reveals Translation Elongation Determinants during Amino Acid Deprivation
Translation elongation plays a key role in cellular homeostasis, and dysregulation of this process has been implicated in various diseases and metabolic disorders. Uncovering the causes of intragenic heterogeneity of translation, especially in contexts of different amino acid deprivations, could help increase our understanding of these disorders and pave the way for novel therapeutics. Ribosome profiling provides accurate measurements for the genome-wide ribosome footprints, which could be utilized to investigate these mechanisms. Here we present Riboclette, a conditional deep learning model featuring a dual output head that uses the mRNA sequence input to accurately predict the ribosome footprint profiles across six amino acid deprivation conditions. Exploiting standard interpretability methods, we identify specific codons related to deprived amino acids, poly-basic regions, and negatively charged amino acids as the primary drivers of the stalling response. Moreover, we use Riboclette to extract motif level drivers for ribosome stalling by performing in silico perturbation experiments. The extracted motifs highlight the cumulative contribution of deprived codons in triggering ribosome stalling, which, depending on the condition, have been identified to affect translation up to ten codons downstream. Moreover, motifs precisely explain stalling at different codon positions, allowing for the differentiation between expected determinants of rare stalling events. Our framework offers an accurate and explainable method for understanding the effect of different amino acid deprivation conditions at a codon resolution to help elucidate the impact of intragenic variations on the regulation of translation elongation.
Open AccessConditional Deep Learning Model Reveals Translation Elongation Determinants during Amino Acid Deprivation
Translation elongation plays a key role in cellular homeostasis, and dysregulation of this process has been implicated in various diseases and metabolic disorders. Uncovering the causes of intragenic heterogeneity of translation, especially in contexts of different amino acid deprivations, could help increase our understanding of these disorders and pave the way for novel therapeutics. Ribosome profiling provides accurate measurements for the genome-wide ribosome footprints, which could be utilized to investigate these mechanisms. Here we present Riboclette, a conditional deep learning model featuring a dual output head that uses the mRNA sequence input to accurately predict the ribosome footprint profiles across six amino acid deprivation conditions. Exploiting standard interpretability methods, we identify specific codons related to deprived amino acids, poly-basic regions, and negatively charged amino acids as the primary drivers of the stalling response. Moreover, we use Riboclette to extract motif level drivers for ribosome stalling by performing in silico perturbation experiments. The extracted motifs highlight the cumulative contribution of deprived codons in triggering ribosome stalling, which, depending on the condition, have been identified to affect translation up to ten codons downstream. Moreover, motifs precisely explain stalling at different codon positions, allowing for the differentiation between expected determinants of rare stalling events. Our framework offers an accurate and explainable method for understanding the effect of different amino acid deprivation conditions at a codon resolution to help elucidate the impact of intragenic variations on the regulation of translation elongation.
- Open Access
Towards improving full-length ribosome density prediction by bridging sequence and graph-based representations
Translation elongation plays an important role in regulating protein concentrations in the cell, and dysregulation of this process has been linked to several human diseases. In this study, we use data from ribo-seq experiments to model ribosome densities, and in turn, predict the speed of translation. The proposed method, RiboGL, combines graph and recurrent neural networks to account for both graph and sequence-based features. The model takes a graph representing the secondary structure of the mRNA sequence as input, which incorporates both sequence and structural codon neighbors. In our experiments, RiboGL greatly outperforms the state-of-the-art RiboMIMO model for ribosome density prediction. We also conduct ablation studies to justify the design choices made in building the pipeline. Additionally, we use gradient-based interpretability to understand how the codon context and the structural neighbors affect the ribosome density at the A-site. By individually analyzing the genes in the dataset, we elucidate how structural neighbors could also potentially play a role in defining the ribosome density. Importantly, since these neighbors can be far away in the sequence, a recurrent model alone could not easily extract this information. This study lays the foundation for understanding how the mRNA secondary structure can be exploited for ribosome density prediction, and how in the future other graph modalities such as features from the nascent polypeptide can be used to further our understanding of translation in general.
Open AccessTowards improving full-length ribosome density prediction by bridging sequence and graph-based representations
Translation elongation plays an important role in regulating protein concentrations in the cell, and dysregulation of this process has been linked to several human diseases. In this study, we use data from ribo-seq experiments to model ribosome densities, and in turn, predict the speed of translation. The proposed method, RiboGL, combines graph and recurrent neural networks to account for both graph and sequence-based features. The model takes a graph representing the secondary structure of the mRNA sequence as input, which incorporates both sequence and structural codon neighbors. In our experiments, RiboGL greatly outperforms the state-of-the-art RiboMIMO model for ribosome density prediction. We also conduct ablation studies to justify the design choices made in building the pipeline. Additionally, we use gradient-based interpretability to understand how the codon context and the structural neighbors affect the ribosome density at the A-site. By individually analyzing the genes in the dataset, we elucidate how structural neighbors could also potentially play a role in defining the ribosome density. Importantly, since these neighbors can be far away in the sequence, a recurrent model alone could not easily extract this information. This study lays the foundation for understanding how the mRNA secondary structure can be exploited for ribosome density prediction, and how in the future other graph modalities such as features from the nascent polypeptide can be used to further our understanding of translation in general.
- Open Access
Interpretable Inflammation Landscape of Circulating Immune cells
Inflammation is a biological phenomenon involved in a wide variety of physiological and pathological processes. Although a controlled inflammatory response is beneficial for restoring homeostasis, it can become unfavorable if dysregulated. In recent years, major progress has been made in characterizing acute and chronic inflammation in specific diseases. However, a global, holistic understanding of inflammation is still elusive. This is particularly intriguing, considering the crucial function of inflammation for human health and its potential for modern medicine if fully deciphered. Here, we leverage advances in the field of single-cell genomics to delineate the full spectrum of circulating immune cell activation underlying inflammatory processes during infection, immune-mediated inflammatory diseases and cancer. Our single-cell atlas of >2 million peripheral blood mononuclear cells from 356 patients and 18 diseases allowed us to learn a foundation model of inflammation in circulating immune cells. The atlas expanded our current knowledge of the biology of inflammation of acute (e.g. inflammatory bowel disease, sepsis) and chronic (e.g. cirrhosis, asthma, and chronic obstructive pulmonary disease) disease processes and laid the foundation to develop a precision medicine framework using unsupervised as well as explainable machine learning. Beyond a disease-centered classification, we charted altered activity of inflammatory molecules in peripheral blood cells, depicting functional biomarkers to further understand mechanisms of inflammation. Finally, we have laid the groundwork for developing precision medicine diagnostic tools for patients experiencing severe acute or chronic inflammation by learning a classifier for inflammatory diseases, presenting cells in circulation as a powerful resource for patient stratification.
Open AccessInterpretable Inflammation Landscape of Circulating Immune cells
Inflammation is a biological phenomenon involved in a wide variety of physiological and pathological processes. Although a controlled inflammatory response is beneficial for restoring homeostasis, it can become unfavorable if dysregulated. In recent years, major progress has been made in characterizing acute and chronic inflammation in specific diseases. However, a global, holistic understanding of inflammation is still elusive. This is particularly intriguing, considering the crucial function of inflammation for human health and its potential for modern medicine if fully deciphered. Here, we leverage advances in the field of single-cell genomics to delineate the full spectrum of circulating immune cell activation underlying inflammatory processes during infection, immune-mediated inflammatory diseases and cancer. Our single-cell atlas of >2 million peripheral blood mononuclear cells from 356 patients and 18 diseases allowed us to learn a foundation model of inflammation in circulating immune cells. The atlas expanded our current knowledge of the biology of inflammation of acute (e.g. inflammatory bowel disease, sepsis) and chronic (e.g. cirrhosis, asthma, and chronic obstructive pulmonary disease) disease processes and laid the foundation to develop a precision medicine framework using unsupervised as well as explainable machine learning. Beyond a disease-centered classification, we charted altered activity of inflammatory molecules in peripheral blood cells, depicting functional biomarkers to further understand mechanisms of inflammation. Finally, we have laid the groundwork for developing precision medicine diagnostic tools for patients experiencing severe acute or chronic inflammation by learning a classifier for inflammatory diseases, presenting cells in circulation as a powerful resource for patient stratification.
- Open Access
- 23 July 2023
- Published by Elsevier in Neurocomputing
- Vol. 554
Unity is strength: Improving the detection of adversarial examples with ensemble approaches
- 23 July 2023
- Published by Elsevier in Neurocomputing
- Vol. 554
Open AccessUnity is strength: Improving the detection of adversarial examples with ensemble approaches
- 1 December 2021
- Published by Elsevier in Information and Computation
- Vol. 281
Combining multi-target regression deep neural networks and kinetic modeling to predict relative fluxes in reaction systems
- 1 December 2021
- Published by Elsevier in Information and Computation
- Vol. 281
Combining multi-target regression deep neural networks and kinetic modeling to predict relative fluxes in reaction systems